Premium
New treatment for tackling plaque psoriasis
Author(s) -
Chaplin Steve,
O'Gorman Susan,
Markham Trevor
Publication year - 2015
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1397
Subject(s) - secukinumab , plaque psoriasis , medicine , psoriasis , dermatology , psoriatic arthritis
Secukinumab (Cosentyx) is licensed for the treatment of moderate to severe plaque psoriasis. Here, Steve Chaplin presents the clinical data relating to its efficacy and Drs Susan O'Gorman and Trevor Markham discuss its place in therapy.